Assessment and management of coagulopathy in neurocritical care
- Author:
Ahmed M SALEM
1
;
David ROH
;
Ryan S KITAGAWA
;
Huimahn A CHOI
;
Tiffany R CHANG
Author Information
- Publication Type:Review
- Keywords: Anticoagulants; Platelet aggregation inhibitors; Blood coagulation disorders; Thrombelastrography; Subarachnoid hemorrhage; Brain injuries, traumatic
- MeSH: Anticoagulants; Blood Coagulation Disorders; Brain; Brain Injuries; Cerebral Hemorrhage; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stroke; Subarachnoid Hemorrhage; Thrombosis
- From: Journal of Neurocritical Care 2019;12(1):9-19
- CountryRepublic of Korea
- Language:English
- Abstract: Coagulopathy may be defined as the loss of balance between hemostatic and fibrinolytic processes resulting in excessive bleeding, intravascular thrombosis or abnormalities in coagulation testing. It is frequently encountered across a wide range of conditions seen in the neurocritical care unit and can contribute to poor outcomes. Early recognition and appropriate management are key, with traumatic brain injury, acute ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage presenting unique challenges to the neurointensivist. We will discuss techniques to assess coagulopathies as well as treatment strategies for the brain injured patient.
